These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 12555162

  • 1. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
    Greenberg BH.
    J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 3. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
    Udelson JE, Konstam MA.
    J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
    [Abstract] [Full Text] [Related]

  • 4. ACE inhibitors: myocardial infarction and congestive heart failure.
    Cody RJ.
    Am Fam Physician; 1995 Nov 01; 52(6):1801-6. PubMed ID: 7484690
    [Abstract] [Full Text] [Related]

  • 5. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR.
    J Card Fail; 2000 Jun 01; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [Abstract] [Full Text] [Related]

  • 6. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators.
    Arch Intern Med; 2006 Mar 27; 166(6):659-66. PubMed ID: 16567606
    [Abstract] [Full Text] [Related]

  • 7. New concepts in post-infarction ventricular remodeling.
    Udelson JE, Patten RD, Konstam MA.
    Rev Cardiovasc Med; 2003 Mar 27; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [Abstract] [Full Text] [Related]

  • 8. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X, Saini HK, Wang J, Gupta SK, Goyal RK, Dhalla NS.
    Expert Rev Cardiovasc Ther; 2005 Jul 27; 3(4):717-32. PubMed ID: 16076281
    [Abstract] [Full Text] [Related]

  • 9. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
    Khattar RS.
    Minerva Cardioangiol; 2003 Apr 27; 51(2):143-54. PubMed ID: 12783070
    [Abstract] [Full Text] [Related]

  • 10. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD, Udelson JE, Konstam MA.
    Curr Opin Cardiol; 1998 May 27; 13(3):162-7. PubMed ID: 9649938
    [Abstract] [Full Text] [Related]

  • 11. What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?
    Reynolds G, Hall AS, Ball SG.
    Eur J Clin Pharmacol; 1996 May 27; 49 Suppl 1():S35-9. PubMed ID: 8834930
    [Abstract] [Full Text] [Related]

  • 12. [Modern therapy of cardiac insufficiency].
    Stojsić D, Jelkić N.
    Med Pregl; 1999 May 27; 52(3-5):113-24. PubMed ID: 10518395
    [Abstract] [Full Text] [Related]

  • 13. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov 27; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 14. ACE inhibitors before or after heart failure?
    Erhardt L.
    Eur J Clin Pharmacol; 1996 Nov 27; 49 Suppl 1():S19-28. PubMed ID: 8834928
    [Abstract] [Full Text] [Related]

  • 15. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM, Sanoski CA, Spinler SA.
    Pharmacotherapy; 2009 Jan 27; 29(1):31-48. PubMed ID: 19113795
    [Abstract] [Full Text] [Related]

  • 16. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA, Molnar J, Arora RR.
    Diabetes Obes Metab; 2008 Jan 27; 10(1):41-52. PubMed ID: 18095949
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M, Nakamura Y, Omura T, Izumi Y, Matsumoto R, Oda S, Takeuchi K, Kim S, Iwao H, Yoshikawa J.
    Heart; 2005 Aug 27; 91(8):1080-5. PubMed ID: 16020603
    [Abstract] [Full Text] [Related]

  • 18. Drugs for left ventricular remodeling in heart failure.
    Frigerio M, Roubina E.
    Am J Cardiol; 2005 Dec 19; 96(12A):10L-18L. PubMed ID: 16399088
    [Abstract] [Full Text] [Related]

  • 19. [Prevention of postinfarction cardiac insufficiency: role of angiotensin converting enzyme inhibitors].
    Guéret P, Cohen-Solal A, Bensaid J.
    Arch Mal Coeur Vaiss; 1992 Nov 19; 85(11 Suppl):1709-16. PubMed ID: 1304144
    [Abstract] [Full Text] [Related]

  • 20. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R, Papa K, Bernocchi P, Gimbatti OJ, Golcea SS, Bettini A, Ceconi C.
    Ital Heart J; 2005 Nov 19; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.